These included number of involved lymph node (Klauber-DeMore et al, 2006), tumour size (Carter et al, 1989), hormone receptor status (Huang et al, 2005) and indicators of tumour proliferation (Aas et al, 2003). This evidence concerns the gene NR4A1 and neoplasm.